Clinical trials: Kallmann Syndrome
Hypogonadotropic Hypogonadism, Kallmann Syndrome
Sequential Therapy for Hypogonadotropic Hypogonadism
The traditional therapy for induction of spermatogenesis in male hypogonadotropic hypogonadism requires both HCG and human menopausal gonadotropin (HMG) or FSH until pregnancy occurs.
- Trial name
- NCT01403532
- Testing
- Traditional intervention for HH using HCG and FSH, Sequential intervention for HH using HCG and FSH, Sequential intervention for HH using HCG and FSH plus zinc
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Kallmann Syndrome, Hypogonadotropic Hypogonadism
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
The purpose of the study is to examine how Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism (IHH) affect reproductive hormones.
- Conditions
- Kallmann Syndrome, Hypogonadotropic Hypogonadism, GnRH Deficiency
- Trial name
- NCT00392756
- Testing
- gonadotropin releasing hormone (GnRH)
- Where
- United States
- Volunteers
- 624 people
- Sponsor
- Massachusetts General Hospital
Kallmann Syndrome, Hypogonadism
Investigating the Regulation of Reproductive Hormones in Adult Men
The purpose of the research study is to learn more about the regulation of reproductive hormones in adult men. We would like to understand what role testosterone and estradiol play in controlling the release of LH (lutenizing…
- Conditions
- Kallmann Syndrome, Hypogonadism, Gonadal Disorder
- Trial name
- NCT00392457
- Testing
- ketoconazole, gonadotropin releasing hormone (GnRH)
- Where
- United States
- Volunteers
- 175 people, healthy volunteers welcome
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)